Arcturus Therapeutics Holdings Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
ARCT chart
What traders are saying about $ARCT
Latest postsArcturus Therapeutics Holdings Inc. news
- Arcturus Therapeutics Narrows Q3 Net Loss to $7.4 Million
www.tokenpost.com ·
- Wells Fargo Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $20
Moomoo ·
- What Arcturus Therapeutics (ARCT) Said on Its Q3 Earnings Call
marketbeat.com ·
- Arcturus Therapeutics Q3 Results: Net loss narrows to $7.4 million
scanx.trade ·
- Arcturus Therapeutics Q3 2026 Earnings Call Transcript
Benzinga ·
- Arcturus Therapeutics Reports Q3 2026: Revenue of $18.3 Million
GuruFocus ·
- Arcturus Therapeutics Holdings Inc reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Arcturus Therapeutics (ARCT) Reports Q3 Loss, Beats Revenue Estimates
Yahoo Finance ·
- Arcturus Therapeutics: Q3 Earnings Snapshot
KVUE ·
- Arcturus Therapeutics Q3 2026 Earnings Call Is Live
TradingView ·
- Arcturus Therapeutics (ARCT) Misses Q3 EPS by 20c
StreetInsider ·
- Arcturus Therapeutics Announces Third Quarter 2026 Financial Results and Pipeline Progress
Yahoo Finance ·
Arcturus Therapeutics Holdings Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $82.0M | $152.3M | $166.8M | $206.0M |
| Net income | -$65.8M | -$80.9M | -$29.7M | $9.3M |
| Diluted EPS | $-2.40 | $-3.00 | $-1.12 | $0.35 |
| Total assets (year end) | $271.1M | $344.1M | $429.4M | $450.4M |
| Cash and equivalents (year end) | $230.9M | $237.0M | $292.0M | $391.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Arcturus Therapeutics Holdings Inc.
- Ticker
- ARCT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1768224
Frequently asked questions
What exchange is Arcturus Therapeutics Holdings Inc. listed on?
Arcturus Therapeutics Holdings Inc. trades on the Nasdaq under the ticker symbol ARCT.
What industry is Arcturus Therapeutics Holdings Inc. in?
Arcturus Therapeutics Holdings Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Arcturus Therapeutics Holdings Inc. headquartered?
Arcturus Therapeutics Holdings Inc.'s business address on file with the SEC is in San Diego, CA.
When does Arcturus Therapeutics Holdings Inc.'s fiscal year end?
Arcturus Therapeutics Holdings Inc.'s fiscal year ends on December 31.
How much revenue did Arcturus Therapeutics Holdings Inc. report?
Arcturus Therapeutics Holdings Inc. reported $82.0M in revenue for calendar year 2025, according to its SEC filings.